These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3125986)

  • 61. Direct evidence for partial target specificity in lymphokine-activated killer thymocytes.
    Leclercq G; De Smedt M; Plum J
    Scand J Immunol; 1990 Oct; 32(4):373-9. PubMed ID: 1700469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differentiation of thymocytes in fetal organ culture: lack of evidence for the functional role of the interleukin 2 receptor expressed by prothymocytes.
    Plum J; De Smedt M
    Eur J Immunol; 1988 May; 18(5):795-9. PubMed ID: 3132397
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
    Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Natural killer cell development and function precede alpha beta T cell differentiation in mouse fetal thymic ontogeny.
    Carlyle JR; Michie AM; Cho SK; Zúñiga-Pflücker JC
    J Immunol; 1998 Jan; 160(2):744-53. PubMed ID: 9580246
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
    McCrady CW; Li F; Grant AJ; Merchant RE; Carchman RA
    Cancer Res; 1988 Feb; 48(3):635-40. PubMed ID: 3257170
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-CD3-activated killer T cells: Interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules.
    Greene AL; Makrigiannis AP; Fitzpatrick L; Hoskin DW
    J Interferon Cytokine Res; 1997 Dec; 17(12):727-37. PubMed ID: 9452360
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Loss of specificity in cytolytic T lymphocyte clones obtained by limit dilution culture of Ly-2+ T cells.
    Shortman K; Wilson A; Scollay R
    J Immunol; 1984 Feb; 132(2):584-93. PubMed ID: 6197466
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations.
    Stanková J; Hoskin DW; Roder JC
    Cell Immunol; 1989 Jun; 121(1):13-29. PubMed ID: 2470516
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prerequisite for the induction of lymphokine-activated killer cells from T lymphocytes.
    Sawada H; Abo T; Sugawara S; Kumagai K
    J Immunol; 1988 May; 140(10):3668-73. PubMed ID: 2896211
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cloned "anomalous" killer cells derived from allogeneic mixed leukocyte culture.
    Benson EM; Giorgi JV; Dvorak AM; Galli SJ; Russell PS
    Cell Immunol; 1987 Jun; 107(1):201-18. PubMed ID: 2438052
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential sensitivity of cytotoxic T lymphocytes and lymphokine-activated killer cells to inhibition by L-ornithine.
    Susskind BM; Sekar J; Tandon PM; Lind DS; Bear HD
    Cell Immunol; 1991 Mar; 133(1):41-54. PubMed ID: 1899361
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Functional studies on the precursors of human lymphokine-activated killer cells.
    Gray JD; Shau HY; Golub SH
    Cell Immunol; 1985 Dec; 96(2):338-50. PubMed ID: 3939293
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL; Charley MR; Calomeni JA; Lipsky PE
    J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of early stages of T lymphocyte development in the thymus cortex and medulla.
    Scollay R; Shortman K
    J Immunol; 1985 Jun; 134(6):3632-42. PubMed ID: 3886788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.